Evidence map›Paper›PMID 37280530›Full record

Observational studyBMC cardiovascular disorders2023

The long-term effects of the Covid-19 infection on cardiac symptoms.

Reza Golchin Vafa, Reza Heydarzadeh, Mohammadhossein Rahmani, Ali Tavan, Soroush Khoshnoud Mansorkhani, Bardia Zamiri, Farhang Amiri, Alireza Azadian, Amin Khademolhosseini, Mohammad Montaseri and 3 more

Registry-linked trialAbstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in BMC cardiovascular disorders, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05715879 (The Long-term Effects of the Covid-19 Infection on Cardiac Symptoms, Should We Have a Realistic Concern?), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05715879 completednot on this map

The Long-term Effects of the Covid-19 Infection on Cardiac Symptoms, Should We Have a Realistic Concern?

Typeobservational_patient_registrySponsorShiraz University of Medical SciencesRan2020 to 2021Enrolled879ConditionsCOVID-19 Pandemic, Dyspnea, Cardiac, Chest SyndromeArmscovid infection, admission to hispital
3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Observational
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Reza Golchin VafaCardiology Department, Shiraz University of Medical Sciences, Shiraz, Iran.
Reza HeydarzadehCardiology Department, Shiraz University of Medical Sciences, Shiraz, Iran.
Mohammadhossein RahmaniProfessor Kojuri Cardiology Clinic, Niayesh St. Niayesh Medical Complex, Shiraz, Iran.
Ali TavanProfessor Kojuri Cardiology Clinic, Niayesh St. Niayesh Medical Complex, Shiraz, Iran.
Soroush Khoshnoud MansorkhaniCardiology Department, Shiraz University of Medical Sciences, Shiraz, Iran.
Bardia ZamiriCardiology Department, Shiraz University of Medical Sciences, Shiraz, Iran.
Farhang AmiriCardiology Department, Shiraz University of Medical Sciences, Shiraz, Iran.
Alireza AzadianCardiology Department, Shiraz University of Medical Sciences, Shiraz, Iran.
Amin KhademolhosseiniProfessor Kojuri Cardiology Clinic, Niayesh St. Niayesh Medical Complex, Shiraz, Iran.
Mohammad MontaseriCardiology Department, Shiraz University of Medical Sciences, Shiraz, Iran.
Nazanin HosseiniProfessor Kojuri Cardiology Clinic, Niayesh St. Niayesh Medical Complex, Shiraz, Iran.
Seyed Ali HosseiniCardiology Department, Shiraz University of Medical Sciences, Shiraz, Iran.
Javad KojuriCardiology Department, Shiraz University of Medical Sciences, Shiraz, Iran. Kojurij@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBesides the lungs, coronavirus disease 2019 (COVID-19) can affect the cardiovascular, digestive, urinary, hepatic, and central nervous systems. Other than its short-term effects, COVID-19 may also cause long-term complications. In this study, we assessed long-term COVID-19 cardiovascular symptoms among patients in a cardiovascular clinic.

methodA retrospective cohort was conducted between October 2020 to May 2021 on patients at an outpatient cardiovascular clinic in Shiraz, Iran. Patients with a history of COVID-19 at least one year before their referral were included. Baseline information was extracted from the clinic's database. Data were collected regarding symptoms like dyspnea, chest pain, fatigue, and palpitations after a year of COVID-19. We also noted any major adverse cardiac events (MACE).

resultsMost common symptoms after a year of COVID-19 were exertional dyspnea (51.2%), dyspnea at rest (41.6%), fatigue (39%), and chest pain (27.1%). The symptoms were more prevalent in hospitalized patients than in non-hospitalized patients. The prevalence of MACE was about 6.1% during the 12-month follow-up, with this rate being higher in those with a history of hospitalization or comorbid diseases.

conclusionThe prevalence of cardiovascular symptoms was fairly high in patients at our clinic a year after COVID-19, and the most common symptom was dyspnea. Hospitalized patients had more MACE. (Clinicaltrial.gov number: NCT05715879)(04/02/2023).

Indexed as

COVID-19Chest PainDyspneaFatigueHumansRetrospective StudiesCardiovascular systemCOVID-19Post-Acute COVID-19 syndromeSigns and symptoms

Identifiers

PMID37280530
PMCPMC10243271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.